AXL therefore plays a role in cancer progression, and AXL has been implicated in a wide variety of malignancies from solid tumors to hematopoietic cancers where it is often associated with poor prognosis. This evidence concerns the gene AXL and hematopoietic and lymphoid cell neoplasm.